heart failure semaglutide in Patients with Obesity-Related and Type 2 Diabetes Beyond obesity: Novo's SELECT re-defines

"The Appetite Suppressant Trap" GLP-1 Medications: The Good, the Bad, and the Clinically Honest A Clinician's Guide to Ozempic, Wegovy, and the Questions Nobody Is Asking By Iris Epstein, RDN, CEDS, CAI | Founder, Nutrition Improvement Center for Restrictive Disorders (NICRD) The #1 Health Trend of 2026 and What Nobody Is Saying About It By now, you have heard the name

In this article Key Takeaways Most therapeutic peptides have short plasma half-lives, often measured in minutes to a few hours, because the body has efficient enzymes that break peptide bonds

,

We get the usual dosing error calls, and all of a sudden theres an explosion of people calling much more regularly about this. The use of semaglutide and other GLP-1 imitators has surged in popularity over the last year as a quick and effective way to manage weight loss

Radiology 288 TargherG.CoreyK